Form 4: FibroGen CFO David DeLucia Reports Share Transaction
SEC Form 4 Filing
David DeLucia, CFO of FibroGen, reports the disposal of 2,325 shares to cover tax obligations.
Summary
- On March 6, 2025, David DeLucia, the Chief Financial Officer of FibroGen Inc. (FGEN), disposed of 2,325 shares of common stock.
- The transaction was executed at a price of $0.39 per share.
- This disposal was to cover a tax obligation resulting from the vesting of restricted stock units.
- Following the transaction, DeLucia directly owns 116,137 shares of FibroGen Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a share transaction for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of the transaction where 2,325 shares were disposed of. |
| 03/07/2025 | Date of signature by Michael Hom, Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.